Abstract
References
Articles referenced by this article (127)
Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Carcinogenesis, (7):1341-1348 2006
MED: 16501252
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.
Proc Natl Acad Sci U S A, (8):3239-3243 1995
MED: 7724545
The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.
Breast Cancer Res Treat, (1):49-56 1996
MED: 8825122
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.
Proc Natl Acad Sci U S A, (10):3799-3804 2006
MED: 16501043
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
Cancer Cell, (5):497-506 2004
MED: 15542433
Functional interaction of beta-catenin with the transcription factor LEF-1.
Nature, (6592):638-642 1996
MED: 8757136
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Am J Pathol, (4):1033-1038 1999
MED: 10514384
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.
Proc Natl Acad Sci U S A, (18):10356-10361 2001
MED: 11526241
Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs, (1-2):56-65 2005
MED: 15942193
Show 10 more references (10 of 127)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Small Peptide Derived from SFRP5 Suppresses Melanogenesis by Inhibiting Wnt Activity.
Curr Issues Mol Biol, 46(6):5420-5435, 29 May 2024
Cited by: 0 articles | PMID: 38920996 | PMCID: PMC11201734
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Oncotarget, 8(2):3259-3273, 01 Jan 2017
Cited by: 9 articles | PMID: 27965462 | PMCID: PMC5356880
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Oncotarget, 7(14):18325-18345, 01 Apr 2016
Cited by: 19 articles | PMID: 26934321 | PMCID: PMC4951291
Mammary gland: From embryogenesis to adult life.
Acta Histochem, 117(4-5):379-385, 20 Mar 2015
Cited by: 21 articles | PMID: 25800977
Review
Mutation of β-catenin in a radiation and estrogen breast cancer model.
Int J Oncol, 46(1):153-160, 22 Oct 2014
Cited by: 2 articles | PMID: 25353218
Go to all (15) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
Eur J Cancer, 45(16):2759-2767, 02 Sep 2009
Cited by: 43 articles | PMID: 19729298
Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
Oncogene, 24(14):2410-2420, 01 Mar 2005
Cited by: 138 articles | PMID: 15735743
TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway.
Dev Dyn, 232(4):969-978, 01 Apr 2005
Cited by: 14 articles | PMID: 15736165
Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Cell Signal, 20(10):1697-1704, 08 May 2008
Cited by: 140 articles | PMID: 18555664
Review